NZ226163A - Pharmaceutical excipients comprising water soluble monoesters of a fatty acid and a polyol as solubilisers of pharmaceutical agents - Google Patents
Pharmaceutical excipients comprising water soluble monoesters of a fatty acid and a polyol as solubilisers of pharmaceutical agentsInfo
- Publication number
- NZ226163A NZ226163A NZ226163A NZ22616388A NZ226163A NZ 226163 A NZ226163 A NZ 226163A NZ 226163 A NZ226163 A NZ 226163A NZ 22616388 A NZ22616388 A NZ 22616388A NZ 226163 A NZ226163 A NZ 226163A
- Authority
- NZ
- New Zealand
- Prior art keywords
- solubilisers
- polyol
- pharmaceutical
- fatty acid
- water soluble
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3730909 | 1987-09-15 | ||
DE3802355 | 1988-01-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ226163A true NZ226163A (en) | 1991-08-27 |
Family
ID=25859774
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ226163A NZ226163A (en) | 1987-09-15 | 1988-09-13 | Pharmaceutical excipients comprising water soluble monoesters of a fatty acid and a polyol as solubilisers of pharmaceutical agents |
Country Status (24)
Country | Link |
---|---|
JP (1) | JP3090666B2 (en) |
KR (1) | KR0131084B1 (en) |
AT (1) | AT395819B (en) |
AU (1) | AU628787B2 (en) |
BE (1) | BE1001204A5 (en) |
CA (1) | CA1338775C (en) |
CH (1) | CH683672A5 (en) |
DK (1) | DK175132B1 (en) |
ES (1) | ES2012118A6 (en) |
FI (1) | FI94837C (en) |
FR (1) | FR2620336B1 (en) |
GB (1) | GB2209671B (en) |
GR (1) | GR1002243B (en) |
HU (1) | HU205010B (en) |
IE (1) | IE61195B1 (en) |
IL (1) | IL87746A (en) |
IT (1) | IT1224886B (en) |
LU (1) | LU87335A1 (en) |
MY (1) | MY103769A (en) |
NL (1) | NL195094C (en) |
NO (1) | NO179434C (en) |
NZ (1) | NZ226163A (en) |
PT (1) | PT88492B (en) |
SE (1) | SE503279C2 (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6007840A (en) * | 1988-09-16 | 1999-12-28 | Novartis Ag | Pharmaceutical compositions comprising cyclosporins |
KR0148748B1 (en) * | 1988-09-16 | 1998-08-17 | 장 크라메르, 한스 루돌프 하우스 | A multiphase cyclosporin composition |
GR1000466B (en) * | 1989-01-28 | 1992-07-30 | Sandoz Ag | Preparation method of novel pharmaceutical forms of cyclosporine |
GB2230440B (en) * | 1989-02-09 | 1993-05-19 | Sandoz Ltd | Novel cyclosporin galenic forms |
GB8916901D0 (en) | 1989-07-24 | 1989-09-06 | Sandoz Ltd | Improvements in or relating to organic compounds |
US6262022B1 (en) | 1992-06-25 | 2001-07-17 | Novartis Ag | Pharmaceutical compositions containing cyclosporin as the active agent |
ES2098739T3 (en) | 1992-05-13 | 1997-05-01 | Sandoz Ltd | OPHTHALMIC COMPOSITIONS CONTAINING A CYCLOSPORIN. |
EP0589843B1 (en) | 1992-09-25 | 2001-11-28 | Novartis AG | Pharmaceutical compositions containing cyclosporins |
DE69426408T2 (en) | 1993-09-28 | 2001-07-12 | Novartis Ag, Basel | Manufacture of soft gelatin capsules |
ATE218359T1 (en) | 1994-11-03 | 2002-06-15 | Novartis Erfind Verwalt Gmbh | NEW PREPARATION FORMS OF CYCLOSPORIN FOR ORAL APPLICATION WITH SIMPLE COMPOSITION AND HIGH BIOAVAILABILITY AND METHOD FOR THE PRODUCTION THEREOF |
US5834017A (en) * | 1995-08-25 | 1998-11-10 | Sangstat Medical Corporation | Oral cyclopsporin formulations |
US5766629A (en) | 1995-08-25 | 1998-06-16 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US5962019A (en) * | 1995-08-25 | 1999-10-05 | Sangstat Medical Corporation | Oral cyclosporin formulations |
US5827822A (en) * | 1996-03-25 | 1998-10-27 | Sangstat Medical Corporation | Cyclosporin a formulations as nanoparticles |
DE19544507B4 (en) | 1995-11-29 | 2007-11-15 | Novartis Ag | Cyclosporin containing preparations |
TW414696B (en) * | 1996-07-01 | 2000-12-11 | Mitsubishi Kagaku Foods Kk | Anti-bacteria agent |
CA2278675A1 (en) | 1997-01-30 | 1998-08-06 | Novartis Ag | Hard gelatine capsules containing pharmaceutical compositions substantially free of any oil |
GB2326337A (en) * | 1997-06-20 | 1998-12-23 | Phares Pharma Holland | Homogeneous lipid compositions for drug delivery |
US7732404B2 (en) | 1999-12-30 | 2010-06-08 | Dexcel Ltd | Pro-nanodispersion for the delivery of cyclosporin |
EP1558215A4 (en) * | 2003-10-14 | 2007-09-12 | Wockhardt Ltd | Sterile gelling agents |
JP5422871B2 (en) * | 2006-10-24 | 2014-02-19 | 不二製油株式会社 | Isoflavones composition |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE624258A (en) * | 1961-10-31 | |||
GB1134878A (en) * | 1966-05-12 | 1968-11-27 | Suga Kazuo | Improvements in and relating to oryzanol solutions and compositions |
FR5986M (en) * | 1966-11-22 | 1968-06-21 | ||
BE787842A (en) * | 1971-08-25 | 1972-12-18 | Sumito Chemical Cy Ltd | PROCESS FOR PREPARING AN AQUEOUS SUSPENSION OF STABLE CRYSTALS OF THE NON-BETA TYPE OF HIGHER FATTY ACID ESTERS OF CHLORAMPHENICOL |
JPS53107408A (en) * | 1977-02-28 | 1978-09-19 | Yamanouchi Pharmaceut Co Ltd | Micellar preparation for rectal infusion |
DE2907460A1 (en) * | 1978-03-07 | 1979-09-13 | Sandoz Ag | NEW RESORBABLE GALENIC COMPOSITIONS |
JPS57128634A (en) * | 1981-02-03 | 1982-08-10 | Eisai Co Ltd | Elastase-containing compound increasing absorption |
EP0179583A1 (en) * | 1984-10-04 | 1986-04-30 | Merck & Co. Inc. | A system for enhancing the water dissolution rate and solubility of poorly soluble drugs |
JPS61280435A (en) * | 1985-04-04 | 1986-12-11 | Kanji Takada | Lymph orienting preparation of cyclosporin |
-
1988
- 1988-09-01 HU HU884518A patent/HU205010B/en unknown
- 1988-09-12 FR FR888811953A patent/FR2620336B1/en not_active Expired - Lifetime
- 1988-09-12 BE BE8801044A patent/BE1001204A5/en not_active IP Right Cessation
- 1988-09-12 CH CH3398/88A patent/CH683672A5/en not_active IP Right Cessation
- 1988-09-12 LU LU87335A patent/LU87335A1/en unknown
- 1988-09-13 CA CA000577214A patent/CA1338775C/en not_active Expired - Lifetime
- 1988-09-13 AU AU22172/88A patent/AU628787B2/en not_active Expired
- 1988-09-13 IE IE277288A patent/IE61195B1/en not_active IP Right Cessation
- 1988-09-13 FI FI884192A patent/FI94837C/en not_active IP Right Cessation
- 1988-09-13 NO NO884052A patent/NO179434C/en not_active IP Right Cessation
- 1988-09-13 NZ NZ226163A patent/NZ226163A/en unknown
- 1988-09-13 PT PT88492A patent/PT88492B/en not_active IP Right Cessation
- 1988-09-13 SE SE8803221A patent/SE503279C2/en not_active IP Right Cessation
- 1988-09-13 GB GB8821443A patent/GB2209671B/en not_active Expired - Lifetime
- 1988-09-14 AT AT0224988A patent/AT395819B/en not_active IP Right Cessation
- 1988-09-14 IL IL87746A patent/IL87746A/en active Protection Beyond IP Right Term
- 1988-09-14 GR GR880100602A patent/GR1002243B/en not_active IP Right Cessation
- 1988-09-14 JP JP63231396A patent/JP3090666B2/en not_active Expired - Lifetime
- 1988-09-14 MY MYPI88001027A patent/MY103769A/en unknown
- 1988-09-14 DK DK198805111A patent/DK175132B1/en not_active IP Right Cessation
- 1988-09-14 IT IT8848349A patent/IT1224886B/en active
- 1988-09-14 KR KR1019880011874A patent/KR0131084B1/en not_active IP Right Cessation
- 1988-09-15 NL NL8802275A patent/NL195094C/en not_active IP Right Cessation
- 1988-09-15 ES ES8802831A patent/ES2012118A6/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NZ226163A (en) | Pharmaceutical excipients comprising water soluble monoesters of a fatty acid and a polyol as solubilisers of pharmaceutical agents | |
HK1022248A1 (en) | Use of a germicidal agent comprising an isothiocyanic acid ester | |
JPS6434946A (en) | Manufacture of polyol fatty acid ester | |
IL92545A0 (en) | Preparation of 2-chloropyridine-3-carboxylic acid esters | |
JPS6416783A (en) | Bridged diazabicycloalkylquinolinecarboxylic acid and esters of same | |
IL87800A0 (en) | Dioxolane-2-carboxylic acids and pharmaceutical compositions comprising them | |
IL78533A0 (en) | Esters of 2-diazo-3-siloxyalkenoic acids and their preparation | |
JPS6416757A (en) | Fatty acid polyoxyalkyl ester sulfonates and manufacture | |
ZA822933B (en) | Aminocyclopentanol acids and esters and their preparation and pharmaceutical formulation | |
IL87185A (en) | Preparation of quinolone- carboxylic acids | |
ZA885328B (en) | Phenylalkenylcarboxylic acids and their esters | |
NZ224923A (en) | 2-methoxymethyl-penem-3-carboxylic acid derivatives and pharmaceutical compositions | |
NZ236061A (en) | Phenoxyphenyl esters of carbamic acid derivatives and pharmaceutical compositions | |
EP0216324A3 (en) | 4-alkoxy-3-pyrrolin-2-on-1-yl-acetic acid alkyl esters and their preparation | |
IL67041A0 (en) | Aminocyclopentane acids and esters and their preparation and pharmaceutical formulation | |
ZA906665B (en) | Use of iodopropargyl esters of a-amino acid derivatives as antimicrobial agents | |
IL97304A0 (en) | Water soluble salts of purpuromycin and pharmaceutical formulations thereof | |
GB8521492D0 (en) | Preparation of diesters of alkanedioic acids | |
GB9009916D0 (en) | Preparation of acrylic acid derivatives | |
NZ234102A (en) | Preparation of alpha-alkoxyacetic acids and their salts | |
NZ234101A (en) | Preparation of alpha-aryloxyacetic acids and their salts | |
DE3266707D1 (en) | Preparation of nitroarylacetic acid esters and derivatives thereof | |
BG51957B2 (en) | Method for the preparation of fatty acid and polyethylene glycol monoesters | |
EP0380985A3 (en) | Esters of 4-aryl-2-halogen imidazol-5-carbonic acid, their preparation and use | |
ZM7984A1 (en) | Formulations of anthelminthics which are sparingly soluble in water and a process for their preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) | ||
ERR | Error or correction |
Free format text: THE OWNER HAS BEEN CORRECTED TO 890887, NOVARTIS AG, LICHTSTRASSE 35, CH-4056 BASEL, CH Effective date: 20140409 |